<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Pharmacyclics LLC — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/pharmacyclics-llc</link>
    <description>Plain-English explanations of patents assigned to Pharmacyclics LLC, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 05:59:45 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/pharmacyclics-llc/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>How Ibrutinib-like Molecules Block Cancer-Causing Proteins</title>
      <link>https://patentbrief.org/patent/us/8957079/pomalyst-pomalidomide</link>
      <description>A chemical design for molecules that permanently latch onto and disable a specific protein called Btk, which is often responsible for the growth of certain blood cancers.</description>
      <pubDate>Tue, 17 Feb 2015 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/8957079/pomalyst-pomalidomide</guid>
    </item>
  </channel>
</rss>
